vs
Northfield Bancorp, Inc.（NFBK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Northfield Bancorp, Inc.的1.8倍（$75.5M vs $41.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 12.7%），Northfield Bancorp, Inc.自由现金流更多（$52.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 15.0%）
诺斯菲尔德银行控股公司是总部位于美国的区域性银行机构，主要服务美国东北部市场，面向个人消费者、中小企业及本地社区客户提供储蓄存款、住房贷款、商业信贷、财富管理等多元银行服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NFBK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$41.3M
营收增速更快
PBYI
高出15.0%
12.7%
自由现金流更多
NFBK
多$38.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
15.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $75.5M |
| 净利润 | $-27.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -1263.3% | 22.7% |
| 净利率 | -1545.5% | — |
| 营收同比 | 12.7% | 27.7% |
| 净利润同比 | -343.6% | — |
| 每股收益（稀释后） | $-0.68 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NFBKPBYI
| Q4 25 | $41.3M | $75.5M | ||
| Q3 25 | $39.2M | $54.5M | ||
| Q2 25 | $38.9M | $52.4M | ||
| Q1 25 | $34.8M | $46.0M | ||
| Q4 24 | $36.7M | $59.1M | ||
| Q3 24 | $31.8M | $80.5M | ||
| Q2 24 | $31.5M | $47.1M | ||
| Q1 24 | $31.3M | $43.8M |
净利润NFBKPBYI
| Q4 25 | $-27.4M | — | ||
| Q3 25 | $10.8M | $8.8M | ||
| Q2 25 | $9.6M | $5.9M | ||
| Q1 25 | $7.9M | $3.0M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $6.5M | $20.3M | ||
| Q2 24 | $6.0M | $-4.5M | ||
| Q1 24 | $6.2M | $-4.8M |
毛利率NFBKPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率NFBKPBYI
| Q4 25 | -1263.3% | 22.7% | ||
| Q3 25 | 37.7% | 17.6% | ||
| Q2 25 | 35.6% | 12.7% | ||
| Q1 25 | 31.0% | 8.7% | ||
| Q4 24 | 38.0% | 22.6% | ||
| Q3 24 | 27.9% | 27.4% | ||
| Q2 24 | 29.1% | -4.6% | ||
| Q1 24 | 27.2% | -5.3% |
净利率NFBKPBYI
| Q4 25 | -1545.5% | — | ||
| Q3 25 | 27.4% | 16.2% | ||
| Q2 25 | 24.6% | 11.2% | ||
| Q1 25 | 22.6% | 6.5% | ||
| Q4 24 | 30.7% | — | ||
| Q3 24 | 20.5% | 25.2% | ||
| Q2 24 | 18.9% | -9.6% | ||
| Q1 24 | 19.9% | -11.0% |
每股收益（稀释后）NFBKPBYI
| Q4 25 | $-0.68 | $0.26 | ||
| Q3 25 | $0.27 | $0.17 | ||
| Q2 25 | $0.24 | $0.12 | ||
| Q1 25 | $0.19 | $0.06 | ||
| Q4 24 | $0.27 | $0.40 | ||
| Q3 24 | $0.16 | $0.41 | ||
| Q2 24 | $0.14 | $-0.09 | ||
| Q1 24 | $0.15 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $164.0M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $690.1M | $130.3M |
| 总资产 | $5.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NFBKPBYI
| Q4 25 | $164.0M | $97.5M | ||
| Q3 25 | $131.7M | $94.4M | ||
| Q2 25 | $97.6M | $96.0M | ||
| Q1 25 | $101.7M | $93.2M | ||
| Q4 24 | $167.7M | $101.0M | ||
| Q3 24 | $232.9M | $96.7M | ||
| Q2 24 | $153.5M | $96.8M | ||
| Q1 24 | $238.8M | $107.2M |
总债务NFBKPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $666.4M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NFBKPBYI
| Q4 25 | $690.1M | $130.3M | ||
| Q3 25 | $719.6M | $115.3M | ||
| Q2 25 | $710.3M | $104.7M | ||
| Q1 25 | $711.1M | $97.1M | ||
| Q4 24 | $704.7M | $92.1M | ||
| Q3 24 | $699.6M | $71.1M | ||
| Q2 24 | $693.0M | $48.5M | ||
| Q1 24 | $698.4M | $51.0M |
总资产NFBKPBYI
| Q4 25 | $5.8B | $216.3M | ||
| Q3 25 | $5.7B | $202.9M | ||
| Q2 25 | $5.7B | $194.9M | ||
| Q1 25 | $5.7B | $196.2M | ||
| Q4 24 | $5.7B | $213.3M | ||
| Q3 24 | $5.7B | $220.7M | ||
| Q2 24 | $5.7B | $205.0M | ||
| Q1 24 | $5.9B | $214.1M |
负债/权益比NFBKPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.95× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $52.5M | $14.4M |
| 自由现金流率自由现金流/营收 | 127.1% | 19.1% |
| 资本支出强度资本支出/营收 | 2.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $89.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NFBKPBYI
| Q4 25 | $53.7M | $14.4M | ||
| Q3 25 | $13.9M | $9.7M | ||
| Q2 25 | $14.1M | $14.1M | ||
| Q1 25 | $9.4M | $3.6M | ||
| Q4 24 | $31.1M | $15.6M | ||
| Q3 24 | $14.0M | $11.0M | ||
| Q2 24 | $6.9M | $1.0M | ||
| Q1 24 | $4.2M | $11.2M |
自由现金流NFBKPBYI
| Q4 25 | $52.5M | $14.4M | ||
| Q3 25 | $13.6M | $9.7M | ||
| Q2 25 | $13.9M | $14.1M | ||
| Q1 25 | $9.2M | $3.6M | ||
| Q4 24 | $30.0M | $15.6M | ||
| Q3 24 | $13.7M | $11.0M | ||
| Q2 24 | $6.7M | $1.0M | ||
| Q1 24 | $3.8M | — |
自由现金流率NFBKPBYI
| Q4 25 | 127.1% | 19.1% | ||
| Q3 25 | 34.6% | 17.7% | ||
| Q2 25 | 35.7% | 26.8% | ||
| Q1 25 | 26.3% | 7.7% | ||
| Q4 24 | 81.6% | 26.4% | ||
| Q3 24 | 43.2% | 13.7% | ||
| Q2 24 | 21.1% | 2.1% | ||
| Q1 24 | 12.1% | — |
资本支出强度NFBKPBYI
| Q4 25 | 2.8% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 1.4% | 0.0% |
现金转化率NFBKPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | 1.10× | ||
| Q2 25 | 1.48× | 2.41× | ||
| Q1 25 | 1.20× | 1.21× | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | 0.54× | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
